Table 1.
Characteristics of participants and eyes included
| Non-proliferative | ||||
|---|---|---|---|---|
| Healthy | Mild/Moderate | Severe | Proliferative | |
| Participants | 21 | 17 | 15 | 18 |
| Age | 56.4±12.2* | 59.5±8.8* | 59.1±11.6* | 49.7±13.6* |
| Gender | ||||
| Male | 5 | 7 | 8 | 10 |
| Female | 16 | 10 | 7 | 8 |
| Height, m | 1.64±0.09 | 1.69±0.10 | 1.68±0.12 | 1.69±0.10 |
| Weight, kg | 80.6±27.3 | 97.6±22.9 | 89.6±15.7 | 96.0±27.6 |
| Body mass index, kg/m2 | 29.4±8.2 | 33.9±6.1 | 31.8±5.5 | 34.0±11.4 |
| Diabetes present, % | 0.0 | 100.0 | 100.0 | 100.0 |
| Positive history of hypertension, % | 0.0 | 64.7 | 86.7 | 50.0 |
| Systolic blood pressure, mm Hg | 123.1±18.9 | 128.8±16.0 | 135.0±24.0 | 126.4±23.6 |
| Diastolic blood pressure, mm Hg | 76.5±12.2 | 69.3±13.7 | 70.7±15.0 | 73.2±11.4 |
| Mean arterial pressure, mm Hg | 92.0±13.8 | 89.1±13.0 | 92.2±15.8 | 90.9±13.5 |
| Eyes | 21 | 17 | 15 | 18 |
| LogMar | -0.03±0.05 | 0.08±0.14 | 0.19±0.19 | 0.11±0.12 |
| MOPP, mm Hg | 46.4±8.1 | 44.3±12.9 | 48.3±10.3 | 45.4±9.9 |
| ETDRS score | 89±3.6 | 81.0±7.8 | 75.3±9.2 | 79.2±7.0 |
| Intraocular pressure | 15.0±2.4 | 12.4±2.4 | 13.1±2.9 | 15.2±4.2 |
| Axial length, mm | 23.9±1.0 | 23.7±1.0 | 23.7±1.4 | 23.4±1.1 |
| Positive history of treatment | ||||
| Panretinal photocoagulation | N/A | 0 | 1 | 9 |
| Anti-VEGF | N/A | 2 | 8 | 6 |
| Treatment naïve | N/A | 15 | 6 | 7 |
*
p=0.86, analysis of variance.
Values are equal to n, mean±SD or percentage.
MOPP, mean ocular perfusion pressure; VEGF, vascular endothelial growth factor; N/A: not applicable.